| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,629,000 | 2,662,000 | 2,838,000 | 3,040,000 | | Cost of Revenue | 1,578,000 | 7,207,000 |
-
|
-
| | | Gross Profit | 1,051,000 | (4,545,000) | 2,838,000 | 3,040,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 720,000 | (4,644,000) | 2,768,000 | 2,751,000 | | Non Recurring |
-
|
-
|
-
| 115,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 331,000 | 99,000 | 70,000 | 174,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,000) | 27,000 | (13,000) | 4,000 | | Earnings Before Interest And Taxes | 322,000 | 126,000 | 57,000 | 178,000 | | Interest Expense | 56,000 | 55,000 | 54,000 | 55,000 | | Income Before Tax | 266,000 | 71,000 | 3,000 | 123,000 | | Income Tax Expense | 82,000 | (5,000) | (18,000) | 66,000 | | Minority Interest |
-
| (3,000) | (3,000) | (2,000) | | | | Net Income From Continuing Ops | 184,000 | 73,000 | 18,000 | 55,000 | | | Non-recurring Events | | Discontinued Operations | (4,000) | 7,000 | (26,000) | 10,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 180,000 | 80,000 | (8,000) | 65,000 | | Preferred Stock And Other Adjustments | (4,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $176,000 | $80,000 | ($8,000) | $65,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
